Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Semin Nephrol. 2018 May;38(3):251–266. doi: 10.1016/j.semnephrol.2018.02.005

Figure 2. Active and inactive vitamin D formulations.

Figure 2

VDR-activating compounds can be broadly divided into two main groups: The first group constitute those that are inactive vitamin D analogues which are prodrugs. These compounds require specific hydroxylation after intake as shown. The second group includes the already active vitamin D anagloues.